Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more episode artwork

EPISODE · Nov 5, 2019 · 8 MIN

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

from JAMA Editors' Summary

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 05, 2019 issue

Episode metadata supplied by the publisher feed · Published Nov 5, 2019

Embed this episode

Ready to play

Lefamulin vs Moxifloxacin for Community-Acquired Pneumonia, Caspofungin vs Fluconazole Prophylaxis in AML, GWAS Review, Treatment of Adolescent Obesity, and more

0:00 8:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 8 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on November 5, 2019.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!